Withdrawal and Penalties
If you wish to withdraw an accepted abstract for any reason, you must send your request in writing by the withdrawal deadline. Withdrawal of an accepted abstract after the withdrawal deadline or failure to present an accepted abstract could result in disqualification from presenting an abstract at IDWeek for the subsequent year.
Send your withdrawal letter by e-mail to: firstname.lastname@example.org
Resolution of Personal Conflicts of Interest
It is the policy of IDWeek that all faculty, abstract reviewers and authors and staff disclose and resolve any real or apparent conflicts of interest relating to the topics of this educational activity. According to the Accreditation Council for Continuing Medical Education (ACCME) Essentials and Standards, IDSA must provide balance, objectivity and scientific rigor in all sponsored educational activities accredited for continuing education (CE). The intent of the disclosure is to provide the audience with information on which they can make their own judgments on program content.
The Infectious Diseases Society of America is accredited by ACCME to provide CE.
Embargo and Copyright Policy
Abstracts are considered official communications of the conference. The presenting author and co-authors must comply with the IDWeek embargo policy that abstracts must be based on results that have not been previously published and are not anticipated to be published before the meeting UNLESS the publication occurs AFTER the deadline for abstract withdrawal. Abstracts must not be submitted if previously presented at a national or international meeting such as, but not limited to: IDSA, SHEA, ASM, CROI, ASMMicrobe or ECCMID. The IDWeek Program Committee will consider abstracts that have been previously submitted at smaller/regional meetings but have not been published in a journal and on the proviso that no rights have previously been transferred; however, all new or updated data must be included in the abstract.
Authors and co-authors transfer any copyrights and agree to release the abstract for future IDWeek publication and grant permission to IDWeek to audio/video record oral presentations for later sale or publication. IDWeek owns the copyrights to all abstracts accepted for presentation in perpetuity.
Please note: In submitting your abstract you also warrant that you have exercised reasonable care to ensure that the article is accurate and does not contain anything which is libelous, or obscene, or infringes on anyone’s copyright, right of privacy, or other rights. All abstracts must be embargoed until Wednesday, Oct. 19, 2022, at 12:01 a.m. ET, with the exception of research findings presented at IDWeek press conferences.
IDWeek 2022 abstracts will be published as an online supplement to Open Forum Infectious Diseases (OFID), the Open Access Journal from IDSA. They will be permanently archived as part of the journal and will be accessible to all journal readers, not only meeting attendees or society members. Abstracts will also be available in the IDWeek Interactive Program and in the official IDWeek app for iPhone and Android. If you do not want your abstract included in OFID, the Interactive Program, or the app, you must withdraw your abstract completely from the meeting prior to the withdrawal deadline.